Skip to main content

letter

. 1995 Apr;71(834):253. doi: 10.1136/pgmj.71.834.253-a

A negative skin biopsy for malignancy does not exclude the possibility of subsequent fatal disease.

J Jacob, C A Austin, D N Slater

PMCID: PMC2398057 PMID: 7784299

253

Images in this article

Figure
on p.253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Clark W. H., Jr, Mihm M. C., Jr Lentigo maligna and lentigo-maligna melanoma. Am J Pathol. 1969 Apr;55(1):39–67. [PMC free article] [PubMed] [Google Scholar]
McGovern V. J., Shaw H. M., Milton G. W., Farago G. A. Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? Histopathology. 1980 May;4(3):235–242. doi: 10.1111/j.1365-2559.1980.tb02918.x. [DOI] [PubMed] [Google Scholar]
McGovern V. J., Shaw H. M., Milton G. W. Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology. 1983 Sep;7(5):673–680. doi: 10.1111/j.1365-2559.1983.tb02279.x. [DOI] [PubMed] [Google Scholar]
Søndergaard K. Histological type and biological behavior of primary cutaneous malignant melanoma. 1. An analysis of 1916 cases. Virchows Arch A Pathol Anat Histopathol. 1983;401(3):315–331. doi: 10.1007/BF00734848. [DOI] [PubMed] [Google Scholar]
Weinstock M. A., Sober A. J. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol. 1987 Mar;116(3):303–310. doi: 10.1111/j.1365-2133.1987.tb05843.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES